The current leadership team at Affimed has a wealth of experience in the biotech and pharmaceutical industries, with a focus on oncology and commercializing innovative drugs. The team has been instrumental in securing investment, launching spin-offs, and leading successful M&A processes. They also have experience heading up departments and managing global programs and projects. The team is well-educated, with degrees in biology, oncology, and carcinogenesis.
View all